Breaking News Instant updates and real-time market news.

BIIB

Biogen

$281.96

58.39 (26.12%)

07:40
10/23/19
10/23
07:40
10/23/19
07:40

Biogen price target raised to $325 from $275 at Cowen

Cowen analyst Phil Nadeau raised his price target on Biogen to $325 from $275 following its better than expected Q3 results. The company also announced they plan to submit a BLA for aducanumab based on a new analyses of the Phase lll's and interaction with the FDA. Though its approval prospects remain unclear, he thinks the company's decision is rational. Nadeau reiterated his Outperform rating on Biogen shares.

BIIB Biogen
$281.96

58.39 (26.12%)

10/23/19
GUGG
10/23/19
UPGRADE
GUGG
Buy
Biogen upgraded to Buy from Neutral at Guggenheim
10/23/19
HCWC
10/23/19
NO CHANGE
Target $335
HCWC
Buy
Biogen price target raised to $335 from $300 at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein raised his price target for Biogen to $335 from $300 saying he was encouraged to learn that a Biologics License Application for aducanumab is anticipated in early 2020 based on constructive FDA discussions around the new complete dataset. Based on the reintroduction of aducanumab to the pipeline, the analyst returned the program to his model. He keeps a Buy rating on Biogen shares.
10/23/19
LEER
10/23/19
UPGRADE
LEER
Outperform
Biogen upgraded to Outperform from Market Perform at SVB Leerink
10/23/19
GUGG
10/23/19
UPGRADE
Target $365
GUGG
Buy
Guggenheim upgrades Biogen, sees over 50% chance of Alzheimer's approval
Guggenheim analyst Yatin Suneja upgraded Biogen to Buy from Neutral with a price target of $365, up from $256. The stock closed Tuesday up 26%, or $58.36, to $281.87. Biogen's key Alzheimer's asset aducanumab is "back in play" following a new analysis of Phase III dataset, Suneja tells investors in a research note. While the robustness of the data will continue to be debated by the Street, there is "more than an even chance" of FDA approval, says the analyst. As a result, Suneja expects Biogen shares to outperform heading into the FDA decision. Aducanumab has the potential to generate $5B-$10B in peak sales, potentially leading to greater than 50% upside appreciation in Biogen shares, contends Suneja. Meanwhile, the analyst believes the company's pipeline "offers optionality" and its commercial products are performing well.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,308.50

-6.21 (-0.47%)

, GOOGL

Alphabet Class A

$1,306.60

-5.99 (-0.46%)

12:27
11/20/19
11/20
12:27
11/20/19
12:27
On The Fly
Game On: An exclusive talk with The Game Kitchen's Enrique Colinet »

In this week's edition of…

GOOG

Alphabet

$1,308.50

-6.21 (-0.47%)

GOOGL

Alphabet Class A

$1,306.60

-5.99 (-0.46%)

MSFT

Microsoft

$150.10

0.26 (0.17%)

SNE

Sony

$61.60

-0.28 (-0.45%)

NTDOY

Nintendo

$0.00

(0.00%)

ATVI

Activision Blizzard

$54.07

0.79 (1.48%)

EA

Electronic Arts

$98.77

2.22 (2.30%)

TTWO

Take-Two

$123.84

0.24 (0.19%)

TCEHY

Tencent

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 04

    Dec

  • 09

    Dec

FCAU

Fiat Chrysler

$15.48

-0.105 (-0.67%)

, GM

General Motors

$35.66

-0.73 (-2.01%)

12:26
11/20/19
11/20
12:26
11/20/19
12:26
Hot Stocks
Fiat Chrysler falls after GM alleges UAW bribes in new lawsuit »

General Motors (GM) filed…

FCAU

Fiat Chrysler

$15.48

-0.105 (-0.67%)

GM

General Motors

$35.66

-0.73 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUN

Sunrun

$13.74

-0.33 (-2.35%)

12:25
11/20/19
11/20
12:25
11/20/19
12:25
Options
Sunrun call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

VRTX

Vertex

$215.06

0.06 (0.03%)

12:24
11/20/19
11/20
12:24
11/20/19
12:24
Recommendations
Vertex analyst commentary  »

Piper Jaffray reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/20/19
11/20
12:17
11/20/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$1.88

0.015 (0.80%)

12:16
11/20/19
11/20
12:16
11/20/19
12:16
Recommendations
Durect analyst commentary  »

H.C. Wainwright sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/20/19
11/20
12:16
11/20/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$38.59

1.355 (3.64%)

, MO

Altria Group

$48.62

1.675 (3.57%)

12:15
11/20/19
11/20
12:15
11/20/19
12:15
Periodicals
FDA shelves plan to require sharp cut in nicotine in cigarettes, Bloomberg says »

The Department of Health…

BTI

British American Tobacco

$38.59

1.355 (3.64%)

MO

Altria Group

$48.62

1.675 (3.57%)

PM

Philip Morris

$84.89

1.44 (1.73%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

GM

General Motors

$35.72

-0.67 (-1.84%)

, FCAU

Fiat Chrysler

$15.49

-0.095 (-0.61%)

12:14
11/20/19
11/20
12:14
11/20/19
12:14
Periodicals
GM sues Fiat Chrysler over UAW bribe claims, AP reports »

General Motors (GM) is…

GM

General Motors

$35.72

-0.67 (-1.84%)

FCAU

Fiat Chrysler

$15.49

-0.095 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAV

Aravive

$11.82

5.13 (76.68%)

12:11
11/20/19
11/20
12:11
11/20/19
12:11
Recommendations
Aravive analyst commentary  »

Aravive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LK

Luckin Coffee

$26.78

-0.49 (-1.80%)

12:05
11/20/19
11/20
12:05
11/20/19
12:05
Options
Luckin Coffee call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

FCX

Freeport McMoRan

$11.32

0.035 (0.31%)

11:55
11/20/19
11/20
11:55
11/20/19
11:55
Options
Freeport McMoRan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
11/20/19
11/20
11:55
11/20/19
11:55
Conference/Events
William Blair SaaS analyst to hold a luncheon meeting »

SaaS Analyst Pfau holds a…

NEWT

Newtek Business Services

$23.09

-0.06 (-0.26%)

11:54
11/20/19
11/20
11:54
11/20/19
11:54
Hot Stocks
Newtek Business Services acquires majority stake in POS on Cloud »

Newtek Business Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$36.93

-0.305 (-0.82%)

, MO

Altria Group

$47.77

0.83 (1.77%)

11:52
11/20/19
11/20
11:52
11/20/19
11:52
Hot Stocks
Cigarette makers rising after FDA said to shelve nicotine cut plans »

Shares of several makers…

BTI

British American Tobacco

$36.93

-0.305 (-0.82%)

MO

Altria Group

$47.77

0.83 (1.77%)

PM

Philip Morris

$84.15

0.7 (0.84%)

IMBBY

Imperial Brands

$0.00

(0.00%)

XXII

22nd Century

$1.44

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$311.52

-0.37 (-0.12%)

11:51
11/20/19
11/20
11:51
11/20/19
11:51
General news
Trump says still talking to China, who wants to make deal »

President Trump said on…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$311.52

-0.37 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

11:49
11/20/19
11/20
11:49
11/20/19
11:49
Periodicals
New 'Pokemon' sells 1.365M units in Japan in first three days, Famitsu says »

Nintendo's latest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$104.76

6.77 (6.91%)

11:48
11/20/19
11/20
11:48
11/20/19
11:48
Hot Stocks
Breaking Hot Stocks news story on Alnylam »

Alnylam trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 04

    Feb

BTI

British American Tobacco

$36.83

-0.405 (-1.09%)

, MO

Altria Group

$47.71

0.77 (1.64%)

11:47
11/20/19
11/20
11:47
11/20/19
11:47
Periodicals
FDA shelves plan to require sharp cut in nicotine in cigarettes, Bloomberg says »

Bloomberg reported that a…

BTI

British American Tobacco

$36.83

-0.405 (-1.09%)

MO

Altria Group

$47.71

0.77 (1.64%)

PM

Philip Morris

$84.12

0.67 (0.80%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

GOOGL

Alphabet Class A

$1,306.83

-5.76 (-0.44%)

, GOOG

Alphabet

$1,308.00

-6.71 (-0.51%)

11:45
11/20/19
11/20
11:45
11/20/19
11:45
Periodicals
Some who pre-ordered Google Stadia still can't access service, Kotaku says »

Some customers who…

GOOGL

Alphabet Class A

$1,306.83

-5.76 (-0.44%)

GOOG

Alphabet

$1,308.00

-6.71 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPC

Marathon Petroleum

$61.17

-0.67 (-1.08%)

11:45
11/20/19
11/20
11:45
11/20/19
11:45
Options
Marathon Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
11/20/19
11/20
11:45
11/20/19
11:45
General news
Treasury's $15 B 16-day cash management bill (CMB) stopped at 1.540% »

Treasury's $15 B…

VZ

Verizon

$59.19

-0.31 (-0.52%)

11:39
11/20/19
11/20
11:39
11/20/19
11:39
Hot Stocks
Verizon and Respond unveil third 5G First Responder Lab cohort »

Verizon, in partnership…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 30

    Jan

AMRN

Amarin

$20.18

-2.56 (-11.26%)

, BRY

Berry Petroleum

$7.13

-1.77 (-19.89%)

11:39
11/20/19
11/20
11:39
11/20/19
11:39
On The Fly
Bearish view of Amarin, Berry downgrades among today's top analyst calls »

Check out today's top…

AMRN

Amarin

$20.18

-2.56 (-11.26%)

BRY

Berry Petroleum

$7.13

-1.77 (-19.89%)

TW

Tradeweb Markets

$44.64

1.38 (3.19%)

CBOE

Cboe Global Markets

$121.85

-0.68 (-0.55%)

CGC

Canopy Growth

$17.43

2.11 (13.77%)

I

Intelsat

$7.38

1.3 (21.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 28

    Dec

SYBT

S.Y. Bancorp

$40.66

-0.04 (-0.10%)

11:37
11/20/19
11/20
11:37
11/20/19
11:37
Hot Stocks
S.Y. Bancorp increases quarterly dividend 4% »

Stock Yards Bancorp,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.